Trials / Completed
CompletedNCT01413789
Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels and One Gel Cream
Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels: BAP Scar Gel, Dermatix, Kelocote and One Gel- Cream: Alhydran
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Study hypothesis: Is Alhydran gel-cream as efficient as silicone gel for skin occlusion and hydration? For this study 16 volunteers and ten patients with healed full thickness burns will be included. After a short period of acclimatization four test areas will be determined. For healthy volunteers the standard zones are located on the inner forearm, two on each forearm. For patients with healed burns the 4 test zones are located on either the healed donor site or the healed skin grafted area. In each test zone baseline measurements will be taken before application of the products.After application of the three silicone gels and the hydrating gel cream the trans epidermal water loss (TEWL) and the moisture content of the stratum corneum will be measured by using the TEWAmeter®TM300 and the Corneometer® CM825 (Courage \& Khazaka).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dermatix | 1 application of Dermatix |
| DRUG | Kelocote | 1 application of Kelocote |
| DRUG | BAP scar gel | 1 application of BAP scar gel |
| DRUG | Alhydran | 1 application of Alhydran |
| DRUG | Bap Scar Care T | 1 application of BAP Scar Care T |
| DRUG | Bap Scar Care S | 1 Application of Bap Scar Care S |
| DRUG | Mepiform | 1 application of Mepiform |
| DRUG | Scar Ban Elastic | 1 application of Scar Ban Elastic |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-08-10
- Last updated
- 2013-04-16
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01413789. Inclusion in this directory is not an endorsement.